Diagnostic Substance Manufacturer Selects EtQ GMP System
FARMINGDALE, NY (1-20-14): EtQ is pleased to announce that a major manufacturer of diagnostic substances has selected the EtQ Reliance GMP System. This company develops diagnostic products for the detection of infectious diseases. EtQ looks forward to demonstrating its value to this company by automating critical GMP processes such as Corrective Action, Audits, and Complaint Handling.
Life Science organizations that choose EtQ’s leading compliance management platform will benefit from capabilities including electronic signature, electronic reporting and the eValidator tool that makes the process of validation on average four times faster than traditional validation methods. The flexibility of EtQ’s automated workflow platform will make common business processes easier while significantly reducing the time it takes to accomplish tasks.
For more information on EtQ’s products and services, or to request a live demo please visit https://www.etq.com/demo/livedemo/ or contact us at 800-354-4476.
EtQ is the leading FDA Compliance, Quality, EHS, and Operational Risk Management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration. Founded in 1992, EtQ has always had a unique knowledge of FDA Compliance, Quality, EHS, and Operational Risk processes, and strives to make overall quality operations and management systems better for businesses. EtQ is headquartered in Farmingdale, NY, with main offices located in EMEA, Limerick and Arizona. EtQ has been providing software solutions to a variety of markets for more than 20 years. For more information, please visit https://www.etq.com or contact us at 800-354-4476.